The dopamine receptor D2 genotype is associated with hyperprolactinemia

To evaluate patients with hyperprolactinemia for the presence of dopamine receptor D2 polymorphisms. Case-control study. Academic research environment. Women and men with pathologic hyperprolactinemia and healthy controls. DNA extraction of peripheral blood, polymerase chain reaction, single-strand...

Full description

Saved in:
Bibliographic Details
Published inFertility and sterility Vol. 84; no. 3; pp. 711 - 718
Main Authors HANSEN, Keith A, YUEYI ZHANG, COLVER, Robert, THO, Sandra P. T, PLOUFFE, Leo JR, MCDONOUGH, Paul G
Format Conference Proceeding Journal Article
LanguageEnglish
Published New York, NY Elsevier Science 01.09.2005
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:To evaluate patients with hyperprolactinemia for the presence of dopamine receptor D2 polymorphisms. Case-control study. Academic research environment. Women and men with pathologic hyperprolactinemia and healthy controls. DNA extraction of peripheral blood, polymerase chain reaction, single-strand conformation polymorphism, DNA sequencing, and restriction digest. Two polymorphisms in exon 7 of the dopamine receptor D2 (DRD2) gene. Polymorphism 1 involves nucleotide 3420 (C to T, 313 His), and polymorphism 2 involves nucleotide 3438 (C to T, 319 Pro). The frequency of DRD2 polymorphism 1 alleles was increased in subjects with hyperprolactinemia. Analysis of the DRD2 genotypes demonstrates an odds ratio of 6.77 (2.39, 19.14; 95% confidence interval) for the polymorphism 1 homozygous state in hyperprolactinemia. A genetic predisposition to hyperprolactinemia is suggested by an excess homozygosity for polymorphism 1 in exon 7 of the DRD2 gene. Previous studies of lactotrophs from prolactinomas have found normal DRD2 receptors but differing isoform density. Homozygosity of polymorphism 1 may influence the distribution of the DRD2 isoforms on the lactotroph. Other potential mechanisms include an association with a molecular defect in a postreceptor signaling mechanism, such as a somatic inactivating mutation in a G1 protein, which could result in autonomous function of the lactotroph. Mutations could also result in different receptor-G protein interactions, such as a Gs instead of Gi, and result in autonomous lactotroph function.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0015-0282
1556-5653
DOI:10.1016/j.fertnstert.2005.03.040